STOCK TITAN

EUBGD Financials

EUBGD
Source SEC Filings (10-K/10-Q) Updated Sep 30, 2025 Currency USD FYE December

This page shows EUBGD (EUBGD) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 72 / 100
Financial Profile 72/100

Based on FY2024 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability
100

EUBGD has an operating margin of 48.9%, meaning the company retains $49 of operating profit per $100 of revenue. This strong profitability earns a score of 100/100, reflecting efficient cost management and pricing power. This is down from 61.9% the prior year.

Growth
8

EUBGD's revenue declined 15.5% year-over-year, from $6.2M to $5.3M. This contraction results in a growth score of 8/100.

Leverage
100

EUBGD carries a low D/E ratio of 0.12, meaning only $0.12 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.

Liquidity
100

With a current ratio of 14.40, EUBGD holds $14.40 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 100/100.

Returns
50

EUBGD's ROE of 17.7% shows moderate profitability relative to equity, earning a score of 50/100. This is down from 25.0% the prior year.

Piotroski F-Score Neutral
4/9

EUBGD passes 4 of 9 financial strength tests. 2 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Mixed
0.91x

For every $1 of reported earnings, EUBGD generates $0.91 in operating cash flow ($1.4M OCF vs $1.5M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$5.3M
YoY-15.5%

EUBGD generated $5.3M in revenue in fiscal year 2024. This represents a decrease of 15.5% from the prior year.

EBITDA
$2.6M
YoY-33.3%

EUBGD's EBITDA was $2.6M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 33.3% from the prior year.

Net Income
$1.5M
YoY-34.8%

EUBGD reported $1.5M in net income in fiscal year 2024. This represents a decrease of 34.8% from the prior year.

EPS (Diluted)
$0.00

EUBGD earned $0.00 per diluted share (EPS) in fiscal year 2024.

Cash & Balance Sheet

Free Cash Flow
N/A
Cash & Debt
$8.5M
YoY-9.0%

EUBGD held $8.5M in cash against $0 in long-term debt as of fiscal year 2024.

Dividends Per Share
N/A
Shares Outstanding
1.70B
YoY+0.0%

EUBGD had 1.70B shares outstanding in fiscal year 2024. This represents an increase of 0.0% from the prior year.

Margins & Returns

Gross Margin
87.0%
YoY-5.4pp

EUBGD's gross margin was 87.0% in fiscal year 2024, indicating the percentage of revenue retained after direct costs. This is down 5.4 percentage points from the prior year.

Operating Margin
48.9%
YoY-13.0pp

EUBGD's operating margin was 48.9% in fiscal year 2024, reflecting core business profitability. This is down 13.0 percentage points from the prior year.

Net Margin
28.2%
YoY-8.4pp

EUBGD's net profit margin was 28.2% in fiscal year 2024, showing the share of revenue converted to profit. This is down 8.4 percentage points from the prior year.

Return on Equity
17.7%
YoY-7.3pp

EUBGD's ROE was 17.7% in fiscal year 2024, measuring profit generated per dollar of shareholder equity. This is down 7.3 percentage points from the prior year.

Capital Allocation

R&D Spending
N/A
Share Buybacks
N/A
Capital Expenditures
N/A

EUBGD Income Statement

Metric Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24 Q4'23
Revenue $1.2M+6.5% $1.1M+18.8% $962K-10.9% $1.1M-35.3% $1.7M+32.1% $1.3M+0.3% $1.3M-23.2% $1.6M
Cost of Revenue $137K+2.1% $134K-22.0% $172K-2.5% $177K-1.5% $179K+5.7% $170K+5.2% $161K+17.5% $137K
Gross Profit $1.1M+7.1% $1.0M+27.7% $790K-12.6% $903K-39.4% $1.5M+36.2% $1.1M-0.4% $1.1M-26.9% $1.5M
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses $386K-16.4% $462K+0.2% $461K-34.3% $702K+65.1% $425K-6.6% $456K+7.8% $422K-40.2% $707K
Operating Income $694K+27.0% $547K+66.4% $329K+63.5% $201K-81.1% $1.1M+66.8% $639K-5.5% $676K-16.9% $813K
Interest Expense N/A N/A N/A N/A N/A N/A N/A N/A
Income Tax $289K+2.6% $282K+43.2% $197K-38.3% $319K-23.1% $414K+44.6% $286K-3.6% $297K-30.2% $426K
Net Income $395K-6.6% $423K+130.5% $183K+195.7% $62K-91.2% $704K+101.9% $348K-6.7% $373K-10.9% $419K
EPS (Diluted) $0.00 $0.00 $0.00 N/A $0.00 $0.00 $0.00 N/A

EUBGD Balance Sheet

Metric Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24 Q4'23
Total Assets $10.3M+6.0% $9.7M+2.6% $9.5M+0.8% $9.4M N/A N/A N/A $10.2M
Current Assets $10.2M+6.3% $9.6M+2.8% $9.3M+1.0% $9.2M N/A N/A N/A $10.0M
Cash & Equivalents $9.6M+4.5% $9.2M+2.7% $8.9M+5.0% $8.5M+2.6% $8.3M-17.5% $10.0M+3.6% $9.7M+3.8% $9.3M
Inventory N/A N/A N/A N/A N/A N/A N/A N/A
Accounts Receivable $507K+36.1% $373K+17.8% $316K-35.6% $491K N/A N/A N/A $633K
Goodwill N/A N/A N/A N/A N/A N/A N/A N/A
Total Liabilities $795K+15.6% $687K-20.6% $865K-11.5% $977K N/A N/A N/A $1.0M
Current Liabilities $570K+10.5% $516K-6.6% $553K-13.7% $640K N/A N/A N/A $847K
Long-Term Debt N/A N/A N/A N/A N/A N/A N/A N/A
Total Equity $9.5M+5.3% $9.0M+4.9% $8.6M+2.2% $8.4M-0.4% $8.4M-13.7% $9.8M+3.6% $9.4M+3.4% $9.1M
Retained Earnings $2.6M+17.9% $2.2M+23.6% $1.8M+11.4% $1.6M N/A N/A N/A $2.3M

EUBGD Cash Flow Statement

Metric Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24 Q4'23
Operating Cash Flow $334K+38.7% $241K-43.3% $424K+40.9% $301K+3.4% $291K-17.0% $351K-15.6% $416K-23.5% $544K
Capital Expenditures N/A N/A N/A N/A N/A N/A N/A -$11
Free Cash Flow N/A N/A N/A N/A N/A N/A N/A $544K
Investing Cash Flow N/A N/A N/A N/A N/A N/A N/A $11
Financing Cash Flow N/A N/A N/A $0 N/A N/A N/A $3
Dividends Paid N/A N/A N/A $0 N/A N/A N/A N/A
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

EUBGD Financial Ratios

Metric Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24 Q4'23
Gross Margin 88.7%+0.5pp 88.2%+6.2pp 82.1%-1.6pp 83.6%-5.6pp 89.3%+2.7pp 86.6%-0.6pp 87.2%-4.4pp 91.6%
Operating Margin 57.0%+9.2pp 47.8%+13.7pp 34.2%+15.6pp 18.6%-45.2pp 63.8%+13.3pp 50.5%-3.1pp 53.7%+4.1pp 49.5%
Net Margin 32.4%-4.5pp 37.0%+17.9pp 19.1%+13.3pp 5.8%-36.4pp 42.1%+14.6pp 27.6%-2.1pp 29.6%+4.1pp 25.6%
Return on Equity 4.2%-0.5pp 4.7%+2.6pp 2.1%+1.4pp 0.7%-7.6pp 8.3%+4.8pp 3.6%-0.4pp 4.0%-0.6pp 4.6%
Return on Assets 3.8%-0.5pp 4.4%+2.4pp 1.9%+1.3pp 0.7% N/A N/A N/A 4.1%
Current Ratio 17.86-0.7 18.56+1.7 16.85+2.5 14.40 N/A N/A N/A 11.84
Debt-to-Equity 0.080.0 0.08-0.0 0.10-0.0 0.12 N/A N/A N/A 0.11
FCF Margin N/A N/A N/A N/A N/A N/A N/A 33.2%

Frequently Asked Questions

EUBGD (EUBGD) reported $5.3M in total revenue for fiscal year 2024. This represents a -15.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

EUBGD (EUBGD) revenue declined by 15.5% year-over-year, from $6.2M to $5.3M in fiscal year 2024.

Yes, EUBGD (EUBGD) reported a net income of $1.5M in fiscal year 2024, with a net profit margin of 28.2%.

EUBGD (EUBGD) reported diluted earnings per share of $0.00 for fiscal year 2024. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

EUBGD (EUBGD) had EBITDA of $2.6M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.

EUBGD (EUBGD) had a gross margin of 87.0% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.

EUBGD (EUBGD) had an operating margin of 48.9% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.

EUBGD (EUBGD) had a net profit margin of 28.2% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.

EUBGD (EUBGD) has a return on equity of 17.7% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.

EUBGD (EUBGD) generated $1.4M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.

EUBGD (EUBGD) had $9.4M in total assets as of fiscal year 2024, including both current and long-term assets.

EUBGD (EUBGD) had 1.70B shares outstanding as of fiscal year 2024.

EUBGD (EUBGD) had a current ratio of 14.40 as of fiscal year 2024, which is generally considered healthy.

EUBGD (EUBGD) had a debt-to-equity ratio of 0.12 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.

EUBGD (EUBGD) had a return on assets of 15.8% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

EUBGD (EUBGD) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

EUBGD (EUBGD) has an earnings quality ratio of 0.91x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

EUBGD (EUBGD) scores 72 out of 100 on our Financial Profile, indicating strong overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.

Back to top